|
1
|
Metzger-Filho O, de Azambuja E, Bradbury
I, Saini KS, Bines J, Simon SD, Dooren VV, Aktan G, Pritchard KI,
Wolff AC, et al: Analysis of regional timelines to set up a global
phase III clinical trial in breast cancer: The adjuvant lapatinib
and/or trastuzumab treatment optimization experience. Oncologist.
18:134–140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bower JE, Greendale G, Crosswell AD, Garet
D, Sternlieb B, Ganz PA, Irwin MR, Olmstead R, Arevalo J and Cole
SW: Yoga reduces inflammatory signaling in fatigued breast cancer
survivors: A randomized controlled trial. Psychoneuroendocrinology.
43:20–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pu Z, Zhang X, Chen Q, Yuan X and Xie H:
Establishment of an expression platform of OATP1B1 388GG and 521CC
genetic polymorphism and the therapeutic effect of tamoxifen in
MCF-7 cells. Oncol Rep. 33:2420–2428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu D, Su C, Jiang M, Shen Y, Shi A, Zhao
F, Chen R, Shen Z, Bao J and Tang W: Fenofibrate inhibited
pancreatic cancer cells proliferation via activation of p53
mediated by upregulation of LncRNA MEG3. Biochem Biophys Res
Commun. 471:290–295. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bertheau P, Lehmann-Che J, Varna M, Dumay
A, Poirot B, Porcher R, Turpin E, Plassa LF, de Roquancourt A,
Bourstyn E, et al: p53 in breast cancer subtypes and new insights
into response to chemotherapy. Breast. 2 Suppl 22:S27–S29. 2013.
View Article : Google Scholar
|
|
6
|
Sana M and Malik HJ: Current and emerging
breast cancer biomarkers. J Cancer Res Ther. 11:508–513. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shah U, Shah R, Acharya S and Acharya N:
Novel anticancer agents from plant sources. Chin J Nat Med.
11:16–23. 2013.(In Chinese). View Article : Google Scholar
|
|
8
|
Khan F, Ahmed F, Pushparaj PN, Abuzenadah
A, Kumosani T, Barbour E, AlQahtani M and Gauthaman K: Ajwa date
(Phoenix dactylifera L.) extract inhibits human breast
adenocarcinoma (MCF7) cells in vitro by inducing apoptosis and cell
cycle arrest. PLoS One. 11:e01589632016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gerber DE: Targeted therapies: A new
generation of cancer treatments. Am Fam Physician. 77:311–319.
2008.PubMed/NCBI
|
|
10
|
He YF, Nan ML, Zhao YW, Sun WY, Li W and
Zhao QC: Design, synthesis and evaluation of antitumor activity of
new rotundic acid acylhydrazone derivatives. Z Naturforsch C.
71:95–103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haraguchi H, Kataoka S, Okamoto S, Hanafi
M and Shibata K: Antimicrobial triterpenes from Ilex integraand the
mechanism of antifungal action. Phytother Res. 13:151–156. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao WM, Wolfender JL, Hostettmann K,
Cheng KF, Xu RS and Qin GW: Triterpenes and triterpenoid saponins
from mussaenda pubescens. Phytochemistry. 45:1073–1078. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhattacharyya J and Almeida MD: Isolation
of the constituents of the root-bark of guettarda platypoda. J Nat
Prod. 48:1481985. View Article : Google Scholar
|
|
14
|
Saimaru H, Orihara Y, Tahsakul P, Kang YH,
Shibuya M and Ebizuka Y: Production of triterpene acids by cell
suspension cultures of Olea europaea. Chem Pharm Bull (Tokyo).
55:784–788. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee TH, Juang SH, Hsu FL and Wu CY:
Triterpene acids from the leaves of planchonella duclitan (Blanco)
bakhuizan. J Chin Chem Soc. 52:1275–1280. 2005. View Article : Google Scholar
|
|
16
|
Fulda S: Inhibitor of apoptosis (IAP)
proteins as therapeutic targets for radiosensitization of human
cancers. Cancer Treat Rev. 38:760–766. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin J, Wang F, Kong Y, Wu R, Zhang G, Wang
N, Wang L, Lu Z and Liang M: Antithrombin III prevents progression
of chronic kidney disease following experimental
ischaemic-reperfusion injury. J Cell Mol Med. 21:3506–3514. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu Z, Cheng D, Yin J, Wu R, Zhang G, Zhao
Q, Wang N, Wang F and Liang M: Antithrombin III protects against
contrast-induced nephropathy. EBioMedicine. 17:101–107. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Antony ML, Kim SH and Singh SV: Critical
role of p53 upregulated modulator of apoptosis in benzyl
isothiocyanate-induced apoptotic cell death. PLoS One.
7:e322672012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu R: Studies on the chemical components
and antitumor activity of ilex rotunda thunb. Ph.D. Thesis.
Guangzhou University of Chinese Medicine; 2009, (In Chinese).
|
|
22
|
He YF, Nan ML, Sun JM, Meng ZJ, Yue FG,
Zhao QC, Yang XH and Wang H: Synthesis, characterization and
cytotoxicity of new rotundic acid derivatives. Molecules.
17:1278–1291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mrózek E, Layman R, Ramaswamy B, Lustberg
M, Vecchione A, Knopp MV and Shapiro CL: Phase II trial of
neoadjuvant weekly nanoparticle albumin-bound paclitaxel,
carboplatin, and biweekly bevacizumab therapy in women with
clinical stage II or III HER2-negative breast cancer. Clin Breast
Cancer. 14:228–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zuo S, Liu C, Wang J, Wang F, Xu W, Cui S,
Yuan L, Chen X, Fan W, Cui M and Song G: IGFBP-rP1 induces p21
expression through a p53-independent pathway, leading to cellular
senescence of MCF-7 breast cancer cells. J Cancer Res Clin Oncol.
138:1045–1055. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Steigerwald C, Rasenberger B, Christmann M
and Tomicic MT: Sensitization of colorectal cancer cells to
irinotecan by the survivin inhibitor LLP3 depends on XAF1
proficiency in the context of mutated p53. Arch Toxicol.
92:2645–2648. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meng X, Bi J, Li Y, Yang S, Zhang Y, Li M,
Liu H, Li Y, Mcdonald ME, Thiel KW, et al: AZD1775 increases
sensitivity to olaparib and gemcitabine in cancer cells with p53
mutations. Cancers (Basel). 10:E1492018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shokouh TZ, Ezatollah A and Barand P:
Interrelationships Between Ki67, HER2/neu, p53, ER, and PR status
and their associations with tumor grade and lymph node involvement
in breast carcinoma subtypes: Retrospective-observational
analytical study. Medicine (Baltimore). 94:e13592015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Verma S and Rao BJ: p53 suppresses
BRCA2-stimulated ATPase and strand exchange functions of human
RAD51. J Biochem. 154:237–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wesierska-Gądek J, Hackl S, Zulehner N,
Maurer M and Komina O: Reconstitution of human MCF-7 breast cancer
cells with caspase-3 does not sensitize them to action of CDK
inhibitors. J Cell Biochem. 112:273–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao QC, Nan ML, He YF and Chen SW:
Application of rotundic acid in the cardiovascular disease
prevention. Chn 201010204596.9. 2010.(In Chinese).
|
|
32
|
Zhao QC, Nan ML, He YF and Chen SW:
Application of rotundic acid in the preparation of lipid-lowering
drugs. CHN 201010204607. 3:2010.(In Chinese).
|
|
33
|
He YF, Zhao QC, Nan ML, Wang HL, Ma JS,
Zhao YW, et al: Application of rotundic acid and its derivatives in
the preparation of anticancer drugs. CHN 201010607515. x:2010.(In
Chinese).
|
|
34
|
Nan ML, Zhao QC, He YF, Chen SW, Zhao YW
and Wang LP: Pharmaceutical compositions from ilex rotunda thunb.
and Its Application. CHN 201010607550. 1:2010.(In Chinese).
|
|
35
|
Zhao QC, He YF, Nan ML, Chen SW, Zhao YW
and Wang LP: Synthesis method of rotundic acid derivatives and
their application in the preparation of cardiovascular disease
prevention drugs. CHN 20110030007. 4:2011.(In Chinese).
|
|
36
|
He YF, Nan ML, Zhao QC, Zhao YW and Yue
FG: Application of amino acid modified rotundic acid derivatives in
the preparation of anticancer drugs. CHN 201110351365.5. 2011.(In
Chinese).
|
|
37
|
Zhang M, Yan H, Li S and Yang J:
Rosmarinic acid protects rat hippocampal neurons from cerebral
ischemia/reperfusion injury via the Akt/JNK3/caspase-3 signaling
pathway. Brain Res. 1657:9–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Venkatesan RS and Sadiq AM: Effect of
morin-5′-sulfonic acid sodium salt on the expression of apoptosis
related proteins caspase 3, Bax and Bcl 2 due to the mercury
induced oxidative stress in albino rats. Biomed Pharmacother.
85:202–208. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mondal A and Bennett LL: Resveratrol
enhances the efficacy of sorafenib mediated apoptosis in human
breast cancer MCF7 cells through ROS, cell cycle inhibition,
caspase 3 and PARP cleavage. Biomed Pharmacother. 84:1906–1914.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang XH, Edgerton S and Thor AD:
Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to
radiation therapy. Int J Oncol. 26:1675–1680. 2005.PubMed/NCBI
|
